Aine Cryts is a freelancer based in Boston. She is a frequent contributor to Managed Healthcare Executive on topics such as diabetes, oncology, hospital admissions and readmissions, senior patients, and health policy.
New Payment Model Improves Cancer Care at Oncology Group
CEO of a Pennsylvania-based oncology group shares how participating in a new value-based model is changing the care approach.
Burnout Hits Oncologists Hard, but Healthcare Systems Can Help
Healthcare systems stand to lose $6 million if burned out physicians choose to resign or work elsewhere. Here are some ways to curb burnout and its associated costs.
Improve Care Coordination in Cancer Care: 2 Key Focus Areas
When caring for cancer patients, improving care coordination in these two areas is key-and it can help reduce healthcare costs.
How Two Health Systems Use Predictive Analytics to Reduce Readmissions
Reducing hospital readmissions requires just the right mix of clinical expertise and predictive analytics. Here are two health systems that are hitting their stride.
Two Ways to Take Charge of CAR T-Cell Therapy Costs
Successful CAR T-cell therapy reimbursement begins with careful payer-provider collaboration and taking these two approaches.
Cancer Vaccine to Prevent Breast, Ovarian Cancer Recurrence Could be Close
In partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
CAR T-cell therapies in treating lymphoma: Pros and cons
Catherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.
Three things health execs need to know about CAR T-cell therapy
Here’s your quick guide to understanding how CAR T-cell therapy could affect patients and payers.
Ovarian cancer could be next application for CAR T-cell therapy
While CAR T-cell therapy has been proven to work for liquid-or blood-cancers, the challenge has been to apply this technology to solid tumors.
Treating frail elderly patients with multiple myeloma requires different approach
Transplant eligibility issues and drug regimen options raise difficult questions when treating older multiple myeloma patients.
Patient experience with immunotherapy: 4 things health execs need to know
CAR T-cell therapies and other immunotherapy give this oncologist’s cancer patients hope for a better quality of life.
Unique payer-provider cancer treatment partnerships
Unique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.
Managing cancer treatment side effects: What payers should know
Moffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.
Four new treatments for acute myeloid leukemia to watch
Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.
This is why you should be excited for upcoming cancer research
Acute myeloid leukemia experts share promising new developments on the oncology horizon.
Four things payers need to know about acute myeloid leukemia
Physicians need to be able to move quickly to care for patients with AML, and they need to have payers on board.
Six ways to reduce hospital readmissions in 2018
Learn from hospitals and managed care organizations at the forefront of successful initiatives. Read more.
Six policy topics every healthcare executive needs to understand
New healthcare terms and topics constantly crop up. Here are six to keep an eye on right now.
Four things millennials can teach older managed care colleagues
Millennials are tomorrow’s leaders, and they bring a lot to the table. Here are some benefits they bring to managed care organizations.
Six ways to transform the patient experience
Hospitals innovatively improve the patient experience as the industry shifts to value-based care.
Bundled payments on ‘pause,’ but not for long
Political uncertainty plagues new payment arrangement, but private payers embrace new model.
Medical marijuana update: Top 3 things health execs should know
Here’s what you need to know about medical marijuana laws, and what they mean for the healthcare system.
Concierge medicine: What health execs need to know
More providers, and even some health plans, are getting in on the action with concierge medicine. Here’s how it works and how it could affect your business.
Patient follow-up: Here’s what you’re doing wrong
AHIP 2017: SummaCare exec shares their best practices for patient care outreach.
Can accountable care drive precision analytics?
AHIP 2017 presentation: The spirit of accountable care keeps providers’ focus on data-driven clinical solutions.
Top three patient care essentials
Oak Street Health co-founder tells AHIP 2017 attendees about its novel approach to patient care.
Five tech trends transforming healthcare
AHIP 2017: Kaveh Savafi, MD, of Accenture, tells Managed Healthcare Executive about the biggest digital trends and their impact on healthcare.
Retail clinic pros and cons: Impact on healthcare spending
A new RAND analysis of retail clinics finds they could be increasing healthcare costs.
Why you need to pay attention to precision medicine
Digital health pioneer Eric Topol talks about plans for a four-year precision medicine study at AHIP 2017.
Patients with complex needs require a custom approach
AHIP 2017: Older adults with complex chronic conditions require payers to “look under the hood.”
2 Clarke Drive Cranbury, NJ 08512